Choices for pharmacologic therapy should be guided by a 10-year global risk assessment score for ASCVD or coronary heart disease using established risk equations (eg, the Framingham risk calculator, ...

Please provide your email address to receive an email when new articles are posted on . BMI reduction below 25 kg/m 2 with tirzepatide was linked to improved 10-year ASCVD risk. Lower BMI was also ...

Individuals with high genetic susceptibility to type 2 diabetes (T2D) who watched television for ≤ 1 hour/day had a lower 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) than ...

Medium and high T2DM genetic risk not linked to increased risk for ASCVD when TV viewing is no more than one hour/day. (HealthDay News) — Medium and high type 2 diabetes (T2D) genetic risks are not ...

Women with uterine fibroids, compared with those without the benign gynecological tumors, have a greater risk of developing atherosclerotic cardiovascular disease (ASCVD) up to 10 years down the line, ...

Study identifies underutilization of testing, with disparities by race and sex. Elevated lipoprotein(a) [Lp(a)] is a common inherited dyslipidemia linked to increased atherosclerotic cardiovascular ...

Menopause was independently associated with an elevated 10-year risk for atherosclerotic cardiovascular disease (ASCVD). Even after comprehensive adjustment for age as well as lifestyle and metabolic ...

Among people with low levels of LDL cholesterol—even those who achieve very large absolute reductions with statin therapy—higher levels of lipoprotein(a) are associated with an increased risk of ...

Findings showed treatment with inclisiran led to clinically meaningful and statistically significant LDL-C lowering compared with placebo and ezetimibe. Topline results were announced from the phase 3 ...